Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introduction: Gastrointestinal tumors are among the most common mesenchymal neoplasms of the gastrointestinal system. They belong to the cells of Cajal that regulate bowel motility. It affects middle age and older from both sexes. Histologically, these tumors express positivity in immunohistochemistry tests (KIT CD117 and DPG1). Case: This is a sixty-three year-old male patient with a past history of tumor resection from the ileum, six years before. Admitted for abdominal pain. The CT scan showed several lesions in liver, colon and bladder. After resection of the lesion located in the upper part of the bladder. Discusion: Diagnosis is done by immunohistochemistry to identify tirosin-kinase receptor CD-117 in 86% to 95% of patients. Other markers like CD34 are often also positive. After surgery, patient received imatininb and remained asymptomatic.
Medrano, R. Meza, N. Silverio,J. Gonzales, G. Factores pronósticos de recurrencia y supervivencia en tumores del estroma gastrointestinal. Gaceta Mexicana de Oncología 2015;14(5):259-267.
Soto, M. Cumana, R. Tumor estromal gastrointestinal esofágico. A propósito de un caso. Revista de la Sociedad Venezolana de Gastroenterología. Volumen 67 N° 1 enero- marzo 2013.
Bayo, A. Tumor estromal gastrointestinal. Intramed journal. Vol5/ número 2
Millán, J. Tumor del estroma gastrointestinal: gistoma de yeyuno. Acta Médica Grupo Ángeles. Volumen 13. No4, octubre – diciembre 2015.
Clachar, g. Resección laparoscópica del tumor del estroma gastrointestinal. Revista medica de Costa rica y Centroamérica LXIX 423-429,2012.
Fuyou Z, Pronostic value of CD117 in cáncer: a meta analysis. Int J Clin Exp Patho 2014:7(3):1012 a1 1021.
Bujele,J. Acosta,O. Guevara, M. Taxa , L. Fujita, R. Identificación de una deleción causante de tumor del estroma gastrointestinal (Gist) por el análisis de los genes KIT y PDGFRA. Horiz Med 2014; 14(4): 43-47.
Bayoll, A. Tumor Estromal Gastrointestinal. Intramed Journal. Vol. 5 Numero 2.
Beltran, M. Tumores del Estroma Gastrointestinal del Duodeno: presentación clínica, estudio diagnóstico y tratamiento. Rev Chil Circ. Vol 66 – Nº4, Agosto 2014; pág. 381-393
Pérez, H. Sánchez, G. Dautant, M. Zuramay, C. González, E. Tumor del Estroma Gastrointestinal del Yeyuno. A propósito de un caso. Revista de la Sociedad Venezolana de Gastroenterología. Vol 67, Nº4. Octubre- Diciembre 2013.
Suarez, J. Motta, G. Rodríguez, C. Jiménez, Z. Tumor del Estroma Gastrointestinal: GISToma de Yeyuno. Acta Medica Grupo Ángeles. Vol 13, Nº4. Octubre-Diciembre 2015.
Beltrán, M. Valenzuela, C. Díaz, R. Haito, Y. Larrain, C. Tumores del Estroma Gastrointestinal del duodeno: revisión de la literatura científica actual con énfasis en el tratamiento. Rev Colombiana Cir. 2014; 29: 140-154.
Nowain A, Bhakta H, Pais S, et al.: Gastrointestinal stromal tumors: clinical profile, pathogenesis, treatment strategies and prognosis. J Gastroenterol Hepatol 20 (6): 818-24, 2005. [PUBMED Abstract]
Casali PG, Jost L, Reichardt P, et al.: Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19 (Suppl 2): ii35-8, 2008. [PUBMED Abstract]
Fernández JA, Parrilla P. Surgical treatment of an advanced GIST: the age of imatinib. Cir Esp 2009;86:3-12. 39. Deshaies I, Cherenfant J, Gusani NJ, Jiang Y, Harvey HA, Kimchi ET, et al. Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment. Ther Clin Risk Manag 2010;6:453-458.
Agaimy A, Wünsch PH, Hofstaedter F, et al.: Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 31 (1): 113-20, 2007. [PUBMED Abstract]
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.